All sponsors

ACADIA Pharmaceuticals Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-33
RECRUITING4
READOUTS ≤12 MONTHS1
Open ACADIA Pharmaceuticals Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
NORLIGHT
NCT07284667
P2RecruitingMajor Depressive Disorder (MDD); Depressive Disorder, Treatment-Resistant1532027-08
ACP-204
NCT06159673
P2/3RecruitingAlzheimer's Disease Psychosis10742028-01
ACP-204
NCT07029581
P2RecruitingLewy Body Dementia Psychosis1802028-02
ACP-204
NCT07095465
P3RecruitingLewy Body Dementia Psychosis1262029-02
ACP-204
NCT06194799
P3Enrolling by invitationAlzheimer's Disease Psychosis7522029-04